Perla, Harsha Teja
Thomson, Viji Samuel http://orcid.org/0000-0002-7241-4443
Attumalil, Thomas V.
Geevar, Tulasi
Alex, Anoop George
Dave, Rutvi G.
Nair, Sukesh C.
Gowri, S. Mahasampath
Mony, Prem K.
George, Paul
Joseph, George
Article History
Accepted: 22 May 2023
First Online: 23 June 2023
Declarations
:
: A one-time grant was received from Sanofi India Ltd to purchase the VerifyNow assay kits for this study. The company had no role in planning, recruiting, overseeing, or analyzing the study, and no data were shared with the company.
: Harsha Teja Perla, Viji S. Thomson, Thomas V. Attumalil, Tulasi Geevar, Anoop George Alex, Rutvi Dave, Sukesh C. Nair, Mahasampath Gowri S, Prem K. Mony, Paul George, and George Joseph declare they have no potential conflicts of interest that might be relevant to the contents of this manuscript.
: This study was approved by the Institutional Review Board and Ethics Committee, Christian Medical College and Vellore, India (Minute No.: 12127)
: Informed consent was obtained from all trial participants.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
: Not applicable.
: HTP: study conception, data interpretation, and manuscript writing. VST: design and conception of the study, data interpretation, intellectual content, and manuscript writing. TVA: design, data interpretation, and manuscript writing. TG: study conception, data interpretation, and writing of the manuscript. AGA: data interpretation and writing of the manuscript. RGD: data verification, analysis, and manuscript editing. SCN: intellectual content, revision, and manuscript writing. MG: data verification, analysis, and manuscript preparation. PKM: design of the study, analysis, and manuscript revision. PG: intellectual content, revision, and manuscript editing. GJ: intellectual content, revision, and manuscript writing.